Unique pharmacodynamic properties conferred by differential binding to BTK, pirtobrutinib vs covalent inhibitors

Ballard, JA; Ebata, K; Randeria, HS; Tinline, G; Lee, T; Hanson, LM; Latham, JA; Cedervall, EP; Chong, J; Del Valle, KB; Collins, BC; Morales, TH; Benedict, TC; Schureck, MA; Bender, ET; Mendoza, C; Molina, D; Nakamoto, M; Shiah, HC; Xu, H; Espada, A; Cano, L; Allerston, CK; Schnier, P; Brandhuber, BJ

CANCER RESEARCH, 2023; 83 (7):